HR Pharmaceuticals, Inc. (HRP) announced that they have entered into an Exclusive Commercial Agreement with Poiesis Medical LLC, under which HRP will license Poiesis's Dual Balloon Catheter (Duette). Under the terms of the agreement, HRP will have exclusive commercialization rights in North America. This product expands HRP's growing urological portfolio across the continuum of care, providing a novel design to help address adverse events associated with Foley catheterization, which is critically important for specific patient populations.
HRP will begin processing North American orders for the Duette Dual Balloon Catheters starting January 2, 2024. Duette is available at most national distributors, including Cardinal Health, McKesson, Medline, and Owens & Minor.
